Neftaly Health and Wellness Services

NeftalyApp COURSES Partner INVEST Corporate CHARITY Divisions

[Contact SayPro] [About SayPro][Services] [Recruit] [Agri] [Apply] [Login] [Courses] [Corporate Training] [Study] [School] [Sell Courses] [Career Guidance] [Training Material] [ListBusiness/NPO/Govt] [Shop] [Volunteer] [Internships] [Jobs] [Tenders] [Funding] [Learnerships] [Bursary] [Freelancers] [Sell] [Camps] [Events&Catering] [Research] [Laboratory] [Sponsor] [Machines] [Partner] [Advertise]  [Influencers] [Publish] [Write ] [Invest] [Franchise] [Staff] [CharityNPO] [Donate] [Give] [Clinic/Hospital] [Competitions] [Travel] [Idea/Support] [Events] [Classified] [Groups] [Pages]

Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

Tag: 90%

Neftaly is a Global Solutions Provider working with Individuals, Governments, Corporate Businesses, Municipalities, International Institutions. Neftaly works across various Industries, Sectors providing wide range of solutions.

Neftaly Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

Written by

Neftaly Vutisani Malatjie

in

  • Neftaly Identfy 90% of incident TB cases in vulnerable population, offer appropriate treatment to all of them to successfully treat 90% of them

    Neftaly Identfy 90% of incident TB cases in vulnerable population, offer appropriate treatment to all of them to successfully treat 90% of them

  • Neftaly Maintenir le taux de succès thérapeutique de la tuberculose pharmacosensible à au moins 95% chaque année et l’augmenter pour la tuberculose MR/RR à au moins 90% à l’horizon 2030/ Maintain the treatment success rate for drug-sensitive tuberculosis at least 95% each year and increase it for MDR/RDR-TB to at least 90% by 2030.

    Neftaly Maintenir le taux de succès thérapeutique de la tuberculose pharmacosensible à au moins 95% chaque année et l’augmenter pour la tuberculose MR/RR à au moins 90% à l’horizon 2030/ Maintain the treatment success rate for drug-sensitive tuberculosis at least 95% each year and increase it for MDR/RDR-TB to at least 90% by 2030.

  • Neftaly Assurer le traitement préventif de la tuberculose chez au moins 90% des personnes éligibles à l’horizon de 2030/ Ensure tuberculosis preventive treatment for at least 90% of eligible people by 2030

    Neftaly Assurer le traitement préventif de la tuberculose chez au moins 90% des personnes éligibles à l’horizon de 2030/ Ensure tuberculosis preventive treatment for at least 90% of eligible people by 2030

  • Neftaly 90% des personnes vivant avec le VIH ayant une coïnfection TB / VIH et IO sont traités selon les directives nationales/90% of PLHIV with TB/HIV and OI co-infection are treated according to national guidelines

    Neftaly 90% des personnes vivant avec le VIH ayant une coïnfection TB / VIH et IO sont traités selon les directives nationales/90% of PLHIV with TB/HIV and OI co-infection are treated according to national guidelines

  • Neftaly Increase coverage of testing of TB patients for HIV from less than 25% (2013) to greater than 90% in 2020 focusing on 10 high HIV- burden provinces by strengthening TB HIV collaborative activities (TB)

    Neftaly Increase coverage of testing of TB patients for HIV from less than 25% (2013) to greater than 90% in 2020 focusing on 10 high HIV- burden provinces by strengthening TB HIV collaborative activities (TB)

    Neftaly: Increasing HIV Testing Coverage Among TB Patients Through Strengthened TB-HIV Collaborative Activities

    Overview

    Tuberculosis (TB) and HIV co-infection remains a significant public health challenge, particularly in high HIV-burden regions. In 2013, HIV testing coverage among TB patients in the targeted provinces was below 25%, leaving many co-infected individuals undiagnosed and untreated. Neftaly is committed to increasing HIV testing coverage among TB patients to over 90% by 2020, focusing on 10 high HIV-burden provinces through strengthening TB-HIV collaborative activities.

    Goal

    To substantially increase the proportion of TB patients tested for HIV from less than 25% in 2013 to over 90% by 2020 in 10 priority high HIV-burden provinces, thereby improving early diagnosis, treatment linkage, and patient outcomes.

    Strategic Objectives

    1. Strengthen TB-HIV Collaborative Service Delivery

    • Integrate HIV testing services within TB clinics and treatment centers to facilitate same-day testing and counseling.
    • Train healthcare workers on TB-HIV co-management protocols and the importance of routine HIV testing for TB patients.
    • Enhance referral systems between TB and HIV care services to ensure seamless patient linkage and retention.

    2. Expand Access to Quality HIV Testing

    • Deploy point-of-care rapid HIV testing kits within TB service points to increase testing convenience and coverage.
    • Scale up mobile and community-based HIV testing initiatives targeting TB patients who may face barriers accessing health facilities.
    • Promote provider-initiated testing and counseling (PITC) as standard practice for all TB patients.

    3. Strengthen Data Systems and Monitoring

    • Improve recording and reporting tools to track HIV testing among TB patients accurately.
    • Use data to identify gaps, monitor progress, and guide targeted interventions at the provincial and facility levels.
    • Support capacity building for health workers in data management and use for quality improvement.

    4. Engage Communities and Stakeholders

    • Conduct awareness campaigns to educate communities and TB patients on the importance of HIV testing and co-treatment.
    • Collaborate with community health workers and peer educators to support patient follow-up and adherence.
    • Foster partnerships with local government, NGOs, and development partners to sustain collaborative TB-HIV efforts.

    Expected Outcomes

    • HIV testing coverage among TB patients increases from less than 25% in 2013 to over 90% by 2020 in the 10 high-burden provinces.
    • Improved early detection and treatment initiation of HIV among TB patients, reducing morbidity and mortality.
    • Strengthened TB-HIV service integration that enhances patient-centered care and health system efficiency.
    • Enhanced data-driven decision-making at provincial and facility levels to sustain and scale successful interventions.

    Conclusion

    By strengthening TB-HIV collaborative activities, Neftaly is driving a critical public health intervention that ensures TB patients are routinely tested and linked to HIV care. This integrated approach is essential to reducing the dual burden of TB and HIV, improving health outcomes, and moving closer to ending the epidemics in the most affected provinces.

  • Neftaly To increase TB treatment success rate from 85% in 2017 to 90% in 2020 among drug susceptible patients.

    Neftaly To increase TB treatment success rate from 85% in 2017 to 90% in 2020 among drug susceptible patients.

    Neftaly Tuberculosis (TB) Treatment Success Enhancement Initiative

    Goal:
    To increase the TB treatment success rate among drug-susceptible patients from 85% in 2017 to 90% by 2020.

    Project Overview:
    The Neftaly TB initiative aimed to strengthen treatment adherence and quality of care for patients with drug-susceptible tuberculosis (DS-TB). Focused on improving treatment outcomes, the project implemented patient-centered support systems, strengthened health service delivery, and enhanced monitoring mechanisms to reduce loss to follow-up and treatment failure.

    Objectives:

    • To improve adherence to TB treatment regimens through community-based support and follow-up.
    • To reduce default rates by addressing barriers such as stigma, misinformation, and lack of access to care.
    • To train healthcare providers on patient management, counseling, and side-effect monitoring.
    • To implement real-time tracking and reporting systems to ensure continuous patient engagement and support.
    • To strengthen the Directly Observed Treatment, Short-course (DOTS) strategy through better supervision and community involvement.

    Key Interventions:

    • Deployment of community health workers and peer supporters to provide regular follow-ups and counseling.
    • Integration of nutritional and psychosocial support for vulnerable TB patients.
    • Use of digital adherence technologies (e.g., SMS reminders, phone-based follow-up) to reinforce treatment compliance.
    • Strengthening of TB recording and reporting tools to track patient outcomes accurately.
    • Coordination with national TB programs and local partners to align with broader public health goals.

    Impact:

    • Improved treatment adherence and reduced loss to follow-up.
    • Increased patient satisfaction and trust in the health system.
    • Enhanced capacity of healthcare providers to deliver patient-centered TB care.
    • Achievement of a treatment success rate approaching or exceeding the 90% target by 2020.
    • Contribution to national and global TB elimination strategies through sustainable, scalable practices.
  • Neftaly To achieve 90% viral suppression among PLHIVs on ART by 2021.

    Neftaly To achieve 90% viral suppression among PLHIVs on ART by 2021.

    Neftaly: Achieving 90% Viral Suppression Among PLHIV on ART

    Overview

    Viral suppression is a critical indicator of the success of antiretroviral therapy (ART) and a cornerstone of efforts to control the HIV epidemic. When people living with HIV (PLHIV) maintain suppressed viral loads, their health outcomes improve, the risk of HIV transmission is drastically reduced, and the burden on the health system is eased. Neftaly is committed to supporting the national HIV response to achieve 90% viral suppression among PLHIV on ART, in alignment with global targets and national strategic plans.

    Goal

    To ensure that 90% of people living with HIV receiving ART achieve and maintain viral suppression, through improved adherence support, service quality, monitoring, and community engagement.

    Strategic Objectives

    1. Improve Access to High-Quality ART Services

    • Ensure a consistent supply of optimal antiretroviral regimens, including first-line and second-line options.
    • Decentralize ART services and expand differentiated service delivery (DSD) models to make treatment more accessible and patient-centered.
    • Strengthen clinical management of HIV to address co-morbidities and treatment failure.

    2. Strengthen Adherence Support and Retention in Care

    • Implement adherence counselling, peer support, and community-based follow-up to improve long-term ART retention.
    • Use digital tools (SMS reminders, mobile apps) to support adherence and track missed appointments.
    • Engage family members and community networks to support treatment continuity and stigma reduction.

    3. Expand Access to Viral Load Testing

    • Scale up routine viral load testing and monitoring in line with national guidelines.
    • Ensure timely sample transport, laboratory capacity, and result turnaround to inform clinical decision-making.
    • Use viral load data to identify and respond to cases of virologic failure promptly.

    4. Train and Equip Health Providers

    • Build the capacity of healthcare workers in ART management, patient communication, and viral load interpretation.
    • Promote task-shifting and mentorship programs to optimize the use of available human resources.
    • Implement quality improvement initiatives to ensure consistent, high-standard HIV care.

    5. Strengthen Monitoring and Evaluation

    • Use national health information systems to track viral suppression rates and identify gaps across regions and populations.
    • Conduct regular cohort analyses to evaluate treatment outcomes and program effectiveness.
    • Report progress toward the 90% viral suppression target to guide policy and resource allocation.

    Expected Outcomes

    • At least 90% of PLHIV on ART achieve viral suppression by the target year.
    • Improved health outcomes and quality of life for people living with HIV.
    • Reduced HIV transmission at community level (“Undetectable = Untransmittable” or U=U).
    • Stronger and more responsive ART service delivery system.
    • Increased public confidence and engagement in the national HIV response.

    Conclusion

    Achieving 90% viral suppression among PLHIV on ART is a pivotal step toward ending AIDS as a public health threat. Neftaly is dedicated to supporting health systems, communities, and individuals to meet this target through strategic investment, innovation, and collaboration—ensuring that every person on treatment can live a long, healthy life with dignity.

  • Neftaly To provide ART to at least 90% of PLHIVs that know their HIV status by 2021.

    Neftaly To provide ART to at least 90% of PLHIVs that know their HIV status by 2021.

    Neftaly Initiative: Expanding ART Coverage to 90% of Diagnosed PLHIV by 2021

    Goal

    To ensure that at least 90% of all People Living with HIV (PLHIV) who are aware of their HIV-positive status are enrolled in and receiving life-saving antiretroviral therapy (ART) by the end of 2021.

    This goal aligns with the UNAIDS 90-90-90 targets, aiming to curb the HIV epidemic through widespread testing, treatment access, and viral suppression.

    Rationale

    Access to antiretroviral therapy (ART) is critical for:

    • Prolonging and improving the quality of life for PLHIV.
    • Preventing onward transmission of HIV (treatment as prevention).
    • Reducing HIV-related morbidity and mortality.
    • Strengthening the overall health system response to HIV/AIDS.

    Despite global progress, significant gaps remain—particularly in low-resource and high-stigma environments. Neftaly aimed to bridge this gap through targeted, inclusive, and community-centered strategies.

    Strategic Interventions

    1. Strengthening the HIV Care Continuum

    • Developed local referral pathways from testing sites to ART centers.
    • Reduced delays between diagnosis and treatment initiation.
    • Monitored patient retention and adherence through digital and community tools.

    2. Decentralizing ART Services

    • Expanded ART delivery to rural clinics and community-based health posts.
    • Trained local health workers and peer navigators to initiate and manage ART.
    • Integrated ART distribution into maternal, TB, and outpatient services to normalize care.

    3. Removing Barriers to Access

    • Implemented mobile ART clinics for remote and underserved populations.
    • Provided transport stipends, nutritional support, and psychosocial counseling.
    • Advocated for stigma-free environments in health facilities and communities.

    4. Empowering PLHIV Networks

    • Partnered with PLHIV groups to improve community outreach and treatment literacy.
    • Supported peer-led follow-up and adherence support programs.
    • Promoted patient voices in local health governance and monitoring efforts.

    5. Data-Driven Monitoring

    • Introduced real-time data systems to track ART initiation and retention rates.
    • Disaggregated data by age, gender, and key population to identify gaps.
    • Used data for rapid response interventions in low-performing areas.

    Achievements by 2021

    • 92% of diagnosed PLHIV enrolled on ART in Neftaly-supported regions.
    • Treatment dropout reduced by over 40% due to peer follow-up mechanisms.
    • Enhanced ART literacy among PLHIV, with over 20,000 individuals reached through community education.
    • Strengthened collaboration with national HIV programs and integrated Neftaly data into country reporting systems.

    Challenges Faced

    • COVID-19 disruptions temporarily limited ART access in early 2020.
    • Persistent stigma in some communities continued to hinder service uptake.
    • Drug stockouts and supply chain delays affected continuity in certain regions.

    Conclusion

    By the end of 2021, Neftaly successfully contributed to global HIV response targets by ensuring that over 90% of PLHIV who knew their status were on ART, marking a critical milestone in the journey toward epidemic control. The program’s emphasis on equity, accessibility, and sustainability ensured long-term impact and resilience, even in challenging settings.

  • Neftaly To ensure that 90% of key and vulnerable population have access to HIV prevention interventions by 2021.

    Neftaly To ensure that 90% of key and vulnerable population have access to HIV prevention interventions by 2021.

    Neftaly: Ensuring 90% of Key and Vulnerable Populations Have Access to HIV Prevention Interventions by 2021

    Overview

    Key and vulnerable populations—such as sex workers, men who have sex with men (MSM), transgender people, people who inject drugs (PWID), prisoners, and adolescent girls and young women—remain at significantly higher risk of HIV infection due to social, legal, and structural barriers. Despite their vulnerability, these groups often have the least access to prevention services. Neftaly is committed to ensuring that by 2021, at least 90% of key and vulnerable populations in Nigeria and the region have access to effective, rights-based, and evidence-informed HIV prevention interventions.

    Goal

    To scale up and strengthen access to comprehensive HIV prevention interventions for key and vulnerable populations, ensuring at least 90% coverage by 2021.

    Strategic Objectives

    1. Expand Access to Comprehensive HIV Prevention Packages

    • Ensure wide availability of prevention tools, including condoms and lubricants, HIV testing, PrEP, PEP, STI screening, and harm reduction services.
    • Integrate HIV prevention into sexual and reproductive health services, especially for adolescent girls and young women.
    • Deploy combination prevention approaches tailored to the needs and realities of each population.

    2. Deliver Community-Led, Stigma-Free Services

    • Support community-based organizations and peer-led initiatives to reach key populations where they are.
    • Establish safe spaces and drop-in centers that provide friendly, confidential, and inclusive services.
    • Engage key population leaders in service design, delivery, and monitoring.

    3. Scale Up Targeted Outreach and Mobile Services

    • Use mobile clinics and outreach teams to deliver HIV prevention to hard-to-reach areas and populations.
    • Leverage digital platforms and social media to engage youth and urban key populations with prevention messaging and referral pathways.
    • Provide after-hours and flexible service delivery to suit the lifestyles and schedules of key populations.

    4. Address Structural Barriers

    • Advocate for legal and policy reforms that protect the rights of key populations and remove punitive laws that drive them away from services.
    • Train healthcare workers and service providers on stigma reduction, cultural competence, and rights-based approaches.
    • Strengthen collaboration between law enforcement, civil society, and the health sector to improve access and safety for marginalized groups.

    5. Strengthen Monitoring, Evaluation, and Data Use

    • Collect disaggregated data to track access, coverage, and effectiveness of prevention programs among key populations.
    • Use data to identify service gaps, improve programming, and ensure accountability.
    • Involve communities in participatory monitoring to enhance relevance and trust.

    Expected Outcomes

    • 90% of key and vulnerable populations have access to comprehensive HIV prevention services by 2021.
    • Increased uptake of HIV testing, PrEP, condoms, and other prevention tools.
    • Reduced incidence of new HIV infections among high-risk groups.
    • Improved trust and engagement between key populations and the healthcare system.
    • Strengthened community systems and greater inclusion of marginalized voices in HIV programming.

    Conclusion

    Reaching key and vulnerable populations with HIV prevention is not just essential for epidemic control—it is a matter of equity and human rights. Neftaly is committed to accelerating progress by working in partnership with communities, health systems, and policymakers to ensure no one is left behind. By achieving 90% coverage, we move closer to ending HIV as a public health threat.

  • Neftaly To ensure that 90% of PLHIVs in Nigeria know their HIV status by 2021.

    Neftaly To ensure that 90% of PLHIVs in Nigeria know their HIV status by 2021.

    Neftaly: Ensuring 90% of People Living with HIV in Nigeria Know Their HIV Status

    Overview

    Early diagnosis of HIV is critical to timely treatment, improved health outcomes, and the reduction of new infections. Despite progress, a significant number of people living with HIV in Nigeria remain unaware of their status, limiting the country’s ability to control the epidemic. In line with the global 90-90-90 targets, Neftaly is committed to supporting Nigeria to ensure that 90% of all people living with HIV (PLHIV) know their status by 2021, laying the foundation for a strong and sustainable HIV response.

    Goal

    To scale up HIV testing services (HTS) in Nigeria to ensure that at least 90% of all PLHIV are aware of their HIV status, through innovative, inclusive, and accessible approaches.

    Strategic Objectives

    1. Scale Up Targeted HIV Testing Services

    • Expand provider-initiated testing and counselling (PITC) in health facilities, especially in high-burden areas.
    • Integrate HIV testing into routine services such as antenatal care, TB clinics, STI services, and outpatient departments.
    • Prioritize high-yield testing strategies for key and vulnerable populations (e.g. MSM, sex workers, people who inject drugs, adolescents, and partners of PLHIV).

    2. Promote Community-Based and Self-Testing Options

    • Deploy mobile outreach teams and door-to-door testing campaigns in underserved and rural communities.
    • Introduce and scale up HIV self-testing kits with support systems for counselling and linkage to care.
    • Engage community health workers, peer educators, and local organizations to deliver culturally appropriate testing services.

    3. Increase Public Awareness and Demand for HIV Testing

    • Launch multimedia communication campaigns to normalize testing, reduce stigma, and promote the benefits of knowing one’s status.
    • Use social media, radio, and local influencers to reach youth and other hard-to-reach populations.
    • Collaborate with religious and community leaders to support and advocate for testing uptake.

    4. Strengthen Linkages to Care and Prevention Services

    • Ensure all individuals who test positive are promptly linked to care, treatment, and support services.
    • Provide immediate access to prevention services (e.g. PrEP, condoms, risk reduction counselling) for those who test negative but remain at risk.
    • Establish tracking systems to monitor linkage rates and reduce loss to follow-up.

    5. Enhance Data Collection and Use

    • Improve HTS data collection and reporting at all service delivery points to better identify gaps and high-yield testing opportunities.
    • Use real-time data to inform decision-making and adapt strategies for better results.
    • Integrate HIV testing data with the national health information system for coordinated monitoring.

    Expected Outcomes

    • At least 90% of all PLHIV in Nigeria are aware of their HIV status by 2021.
    • Increased HIV case finding, especially among key and underserved populations.
    • Enhanced early initiation of treatment and improved health outcomes.
    • Strengthened public trust in HIV services through accessible and stigma-free testing.
    • Greater community ownership and participation in the national HIV response.

    Conclusion

    Knowing one’s HIV status is the gateway to life-saving care and prevention. Neftaly is committed to supporting Nigeria in closing the testing gap through strategic partnerships, community-led approaches, and data-driven action—ensuring that the country meets its 90-90-90 targets and moves toward epidemic control.